Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02137278
Other study ID # ASL4/CARD/01
Secondary ID
Status Completed
Phase Phase 3
First received May 1, 2014
Last updated December 28, 2015
Start date March 2014
Est. completion date December 2015

Study information

Verified date December 2015
Source Gruppo Italiano Multidisciplinare per lo Studio della Sincope
Contact n/a
Is FDA regulated No
Health authority Italy: Ministry of Health
Study type Interventional

Clinical Trial Summary

Investigate clinical effects (reduction of number of syncope and associate symptoms) of suspension of vasoactive drugs in patients affected by vasodepressor reflex syncope.


Description:

Several drugs which are commonly used in clinical practice, such as antihypertensive, antiarrhythmic and psychiatric drugs, are associated with orthostatic hypotension and syncope. This phenomenon is much more evident in the elderly and with multiple therapies. The present study was aimed to investigate, in patients affected by reflex syncope, the clinical effects (reduction in syncope recurrence and associated symptoms) and the laboratory tests (negativization of carotid sinus massage and tilt table test) when such drugs are discontinued or reduced


Recruitment information / eligibility

Status Completed
Enrollment 58
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

Patients assuming chronic (>1 year) vasoactive therapy affected by reflex recurrent (>2 episodes) syncopes who have a positive dominant vasodepressor or mixed response to tilt table test and/or carotid sinus massage

Exclusion Criteria:

1. Orthostatic hypotension defined as fall in systolic blood pressure >20 mmHg during the first 3 minutes of active standing

2. Competing diagnosis of syncope different from hypotensive reflex syncope

3. Reflex syncope with negative response to carotid sinus massage and tilt table test

4. Cardioinhibitory reflex syncope which requires permanent cardiac pacing

5. Severe hypertension which requires treatment (>150/95)

6. Structured heart disease which requires hypotensive therapy in order to prevent acute heart failure

7. Cardiac hypotensive therapy in order to prevent recurrences

8. Previous stroke or transient ischemic attacks

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Vasoactive drug therapies
Continue current vasoactive therapy
Other:
Stop/reduce vasoactive drugs
Discontinuation of any vasoactive therapy or reduction of vasoactive drug therapies as much as possible according to clinical judgment.

Locations

Country Name City State
Italy Dipartimento di Cardiologia, Ospedali del Tigullio Lavagna

Sponsors (1)

Lead Sponsor Collaborator
Gruppo Italiano Multidisciplinare per lo Studio della Sincope

Country where clinical trial is conducted

Italy, 

References & Publications (4)

Brignole M, Menozzi C, Gaggioli G, Musso G, Foglia-Manzillo G, Mascioli G, Fradella G, Bottoni N, Mureddu R. Effects of long-term vasodilator therapy in patients with carotid sinus hypersensitivity. Am Heart J. 1998 Aug;136(2):264-8. — View Citation

Gaggioli G, Brignole M, Menozzi C, Devoto G, Oddone D, Gianfranchi L, Gostoli E, Bottoni N, Lolli G. A positive response to head-up tilt testing predicts syncopal recurrence in carotid sinus syndrome patients with permanent pacemakers. Am J Cardiol. 1995 Oct 1;76(10):720-2. — View Citation

Podoleanu C, Maggi R, Brignole M, Croci F, Incze A, Solano A, Puggioni E, Carasca E. Lower limb and abdominal compression bandages prevent progressive orthostatic hypotension in elderly persons: a randomized single-blind controlled study. J Am Coll Cardio — View Citation

Solari D, Maggi R, Oddone D, Solano A, Croci F, Donateo P, Brignole M. Clinical context and outcome of carotid sinus syndrome diagnosed by means of the 'method of symptoms'. Europace. 2014 Jun;16(6):928-34. doi: 10.1093/europace/eut283. Epub 2013 Sep 20. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Acute study Quality of life assessed by means of the Specific symptom Scale - Orthostatic Hypotension questionnaire. Results of carotid sinus massage and tilt table test 1 month No
Primary Recurrence of syncope or presyncope and adverse events Combined end-point of rate of patients with recurrence of (pre)syncope and adverse events From date of randomization until the date of first documented syncope or adverse event, whichever came first, assessed up to 2 years Yes
Secondary Syncope Recurrence of syncope From date of randomization until the date of first documented syncope or adverse event, whichever come first, assessed up to 2 years No
Secondary Presyncope Burden of presyncope, measured as number of episodes of presyncope/s per month assessed up to 2 years by mean of a patient's diary From date of randomization until the date of first documented syncope or adverse event, whichever came first, assessed up to 2 years No